Rapid Desensitization for Hypersensitivity Reactions to Chemotherapeutic Drugs; A Case Series

AuthorDelara Babaieen
AuthorBibi Shahin Shamsianen
AuthorNader Momtazmaneshen
AuthorHamidreza Godarzipouren
AuthorMehrdad Amirmoinien
AuthorBahram Bashardousten
AuthorMasoomeh Ebrahimien
AuthorMahdieh Vahedien
AuthorReza Ghaemien
AuthorMehrnaz Mesdaghien
Issued Date2019-04-30en
AbstractUsage of cancer chemotherapeutics drugs can be associated with adverse drug reactions. When IgE-mediated drug reactions are formed following administration of a chemotherapeutics drug that is a drug of choice, drug desensitization protocols can be helpful. HSR can be allergic or nonallergic, but the clinical manifestations are similar. RDD is effective when used appropriately, however it is often over utilized instead of performing a drug challenge. RDD is both an acceptable approach and a high-risk treatment modality in patients, in whom the offending agent is the first choice in chemotherapy. The safety of this modality has been acceptable in large studies. The side effects are often less frequent and less severe by repeating the protocol. We present 4 cases of successful desensitization in cancer patients, who have developed IgE- mediated reactions to their major chemotherapy drug.en
DOIhttps://doi.org/10.22037/ijpr.1999.1100664en
KeywordAdverse drug reactionen
KeywordCancer chemotherapy drugsen
KeywordDrug hypersensitivity syndromesen
KeywordDrug desensitizationen
PublisherBrieflandsen
TitleRapid Desensitization for Hypersensitivity Reactions to Chemotherapeutic Drugs; A Case Seriesen
TypeOriginal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijpr-18-1047.pdf
Size:
205.69 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF